title: Total antioxidant intake in relation to prostate cancer incidence in the Health Professionals Follow-Up Study.
abstract: Epidemiologic evidence on the association of antioxidant intake and prostate cancer incidence is inconsistent. Total antioxidant intake and prostate cancer incidence have not previously been examined. Using the ferric-reducing antioxidant potential (FRAP) assay, the total antioxidant content (TAC) of diet and supplements was assessed in relation to prostate cancer incidence. A prospective cohort of 47,896 men aged 40-75 years was followed from 1986 to 2008 for prostate cancer incidence (N = 5,656), and they completed food frequency questionnaires (FFQs) every 4 years. A FRAP value was assigned to each item in the FFQ, and for each individual, TAC scores for diet, supplements and both (total) were calculated. Major contributors of TAC intake at baseline were coffee (28%), fruit and vegetables (23%) and dietary supplements (23%). In multivariate analyses for dietary TAC a weak inverse association was observed [highest versus lowest quintiles: 0.91 (0.83-1.00, p-trend = 0.03) for total prostate cancer and 0.81 (0.64-1.01, p-trend = 0.04) for advanced prostate cancer]; this association was mainly due to coffee. No association of total TAC on prostate cancer incidence was observed. A positive association with lethal and advanced prostate cancers was observed in the highest quintile of supplemental TAC intake: 1.28 (0.98-1.65, p-trend < 0.01) and 1.15 (0.92-1.43, p-trend = 0.04). The weak association between dietary antioxidant intake and reduced prostate cancer incidence may be related to specific antioxidants in coffee, to nonantioxidant coffee compounds or other effects of drinking coffee. The indication of increased risk for lethal and advanced prostate cancers with high TAC intake from supplements warrants further investigation.
authors: Department of Epidemiology, Harvard School of Public Health, Boston, MA; Division of Cancer, Surgery and Transplantation, Oslo University Hospital, Oslo, Norway; Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
authors: Kjell M
authors: KM
authors: Russnes
authors: Kathryn M
authors: KM
authors: Wilson
authors: Mara M
authors: MM
authors: Epstein
authors: Julie L
authors: JL
authors: Kasperzyk
authors: Meir J
authors: MJ
authors: Stampfer
authors: Stacey A
authors: SA
authors: Kenfield
authors: Sigbjørn
authors: S
authors: Smeland
authors: Rune
authors: R
authors: Blomhoff
authors: Edward L
authors: EL
authors: Giovannucci
authors: Walter C
authors: WC
authors: Willett
authors: Lorelei A
authors: LA
authors: Mucci
mesh_terms: D000328:Adult; D000368:Aged; D000975:Antioxidants / Q000008:administration & dosage*; D015331:Cohort Studies; D005500:Follow-Up Studies; D006282:Health Personnel; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011471:Prostatic Neoplasms / Q000453:epidemiology*; D011795:Surveys and Questionnaires
chemical_list: D000975:Antioxidants
keywords: antioxidants; diet; oxidative stress; prostate cancer; risk factors
references: Ann Epidemiol. 2012 Nov;22(11):814-20
references: 22986088
references: Int J Cancer. 2013 Sep 15;133(6):1447-51
references: 23444117
references: Nutrition. 2009 Jul-Aug;25(7-8):839-46
references: 19398299
references: CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
references: 21296855
references: Int J Cancer. 2004 Mar;109(1):119-24
references: 14735477
references: Nature. 1998 Apr 9;392(6676):559
references: 9560150
references: JAMA. 2009 Jan 7;301(1):39-51
references: 19066370
references: Biochem Biophys Res Commun. 2010 Oct 1;400(4):466-70
references: 20732307
references: Nutr Cancer. 2006;54(1):94-101
references: 16800777
references: J Nutr. 2005 Sep;135(9):2212-8
references: 16140900
references: Curr Opin Lipidol. 2005 Feb;16(1):47-54
references: 15650563
references: J Natl Cancer Inst. 2011 Jun 8;103(11):876-84
references: 21586702
references: J Nutr. 2003 Sep;133(9):2812-9
references: 12949370
references: Mutat Res. 2009 Mar 31;674(1-2):36-44
references: 18977455
references: Anal Biochem. 1996 Jul 15;239(1):70-6
references: 8660627
references: Mol Nutr Food Res. 2011 Feb;55(2):185-97
references: 20827676
references: J Natl Cancer Inst. 2006 Feb 15;98(4):245-54
references: 16478743
references: Cancer Res. 2003 Aug 1;63(15):4295-8
references: 12907593
references: J Natl Cancer Inst. 2007 May 16;99(10):754-64
references: 17505071
references: Cancer Causes Control. 2002 Aug;13(6):573-82
references: 12195647
references: JAMA. 2009 Jan 7;301(1):52-62
references: 19066368
references: Pharmacogenetics. 2003 Mar;13(3):145-57
references: 12618592
references: Nutr J. 2010 Jan 22;9:3
references: 20096093
references: Nutrition. 2001 Oct;17(10):888-95
references: 11684397
references: Eur J Nutr. 2011 Oct;50(7):507-22
references: 21184087
references: Int J Cancer. 2012 Aug 15;131(4):E544-54
references: 22072493
references: Cancer Epidemiol. 2011 Aug;35(4):353-61
references: 21145797
references: Cancer Causes Control. 2005 Aug;16(6):643-50
references: 16049802